UBS’s CytRx Corp CYTR Stock Holding History

UBS’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$4K	Buy	258 +59	+30%	+$1.17K	﹤0.01%	9731
2014 Q2	$5K	Sell	199 -21,777	-99%	-$496K	﹤0.01%	9604
2014 Q1	$460K	Buy	21,976 +21,974	+1,098,700%	+$780K	﹤0.01%	4323
2013 Q4	$0	Sell	2 -690	-100%	-$12.6K	﹤0.01%	11417
2013 Q3	$13K	Buy	692 +673	+3,542%	+$9.92K	﹤0.01%	8615
2013 Q2	$0	Buy	+19	New	+$280	﹤0.01%	10245

Other funds holding CYTR

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

UBS's CYTR Position: Q3 2014 in Review

UBS increased its CytRx Corp (CYTR) stake by 30% in Q3 2014, buying an estimated $1.17K and bringing the position to 258 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #9731.

UBS first reported a position in CYTR in Q2 2013 and has held it in 6 quarters since. The position peaked at $460K in Q1 2014. 69 funds tracked by Wall St. Rank hold CYTR as of Q3 2014.

UBS held 258 shares of CytRx Corp worth $4K as of Q3 2014.
UBS bought 59 CytRx Corp shares in Q3 2014, an estimated $1.17K.
CytRx Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9731 holding.
UBS first reported a position in CytRx Corp in Q2 2013 and has held it in 6 quarters since.
UBS's CytRx Corp position peaked at $460K in Q1 2014.
69 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.